Proteomic analysis of non-adherent cancer cells derived from ascites of advanced-stage ovarian cancer patients found that plectin expression was significantly higher in samples from chemonaïve patients at diagnosis compared to patients with recurrent disease after chemotherapy [97,131]. The gene discussed is PLEC; the disease is cancer.